Arcturus Therapeutics Holdings Inc. 13D and 13G filings for Vallon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 9:41 pm Purchase |
2021-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Arcturus Therapeutics Holdings Inc. ARCT |
28,125 12.380% |
28,125 (New Position) |
Filing |